Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Aug 22, 2024 (2 years ago)

TIRZEPATIDE 20 mg/2mL

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

TIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-01

Affected NDC 84139-0210-01

Compare with the code on your package — it is the most precise check available.

Drug: Tirzepatide

Recalling firm
ProRx LLC
NDC code
84139-210-01
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0655-2024 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Tirzepatide recalls

See all

Other recalls by ProRx LLC

All 2024 recalls